Inhibikase Therapeutics IKT
NASDAQ IKT
$1.63 -0.03 (-1.81%)
At close: Oct 22, 2026 · 4:00 PM EDT

Inhibikase Therapeutics (IKT) Change in Other Operating Assets (2020 - 2026)

Updated

Analysis

Inhibikase Therapeutics (IKT) Change in Other Operating Assets (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Assets Change (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -122.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 188.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 330.00 Mn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 13.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Inhibikase Therapeutics 284.55 Mn -300.92 Mn - 1.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.56 Mn
Mar 31, 2026 522,994.00
Dec 31, 2025 553,224.00
Sep 30, 2025 914,747.00
Jun 30, 2025 -99,269.00
Mar 31, 2025 215,809.00
Dec 31, 2024 617,973.00
Sep 30, 2024 -133,397.00
Jun 30, 2024 83,138.00
Mar 31, 2024 31,091.00
Dec 31, 2023 -252,588.00
Sep 30, 2023 -223,047.00
Jun 30, 2023 -850,569.00
Mar 31, 2023 590,204.00
Dec 31, 2022 -119,220.00
Sep 30, 2022 -292,192.00
Jun 30, 2022 162.00
Mar 31, 2022 120,648.00
Dec 31, 2021 803,956.00
Sep 30, 2021 -986,973.00
API Access

Inhibikase Therapeutics Change in Other Operating Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-assets&ticker=IKT&period=max&api_key=YOUR_API_KEY